Literature DB >> 29533671

Update in Pulmonary Vascular Disease 2016 and 2017.

Evan L Brittain1,2,3, Thennapan Thennapan4, Bradley A Maron5,6, Stephen Y Chan7, Eric D Austin3,8, Edda Spiekerkoetter9,10, Harm J Bogaard11, Christophe Guignabert12,13, Roxane Paulin14, Roberto F Machado15, Paul B Yu5.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29533671      PMCID： PMC6034126          DOI： 10.1164/rccm.201801-0062UP

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  138 in total

1.  Tryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary Hypertension.

Authors:  Robert J Aiello; Patricia-Ann Bourassa; Qing Zhang; Jeffrey Dubins; Daniel R Goldberg; Stéphane De Lombaert; Marc Humbert; Christophe Guignabert; Maria A Cavasin; Timothy A McKinsey; Vishwas Paralkar
Journal:  J Pharmacol Exp Ther       Date:  2016-12-07       Impact factor: 4.030

2.  Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension.

Authors:  Anna R Hemnes; Min Zhao; James West; John H Newman; Stuart Rich; Stephen L Archer; Ivan M Robbins; Timothy S Blackwell; Joy Cogan; James E Loyd; Zhongming Zhao; Christa Gaskill; Christopher Jetter; Jonathan A Kropski; Susan M Majka; Eric D Austin
Journal:  Am J Respir Crit Care Med       Date:  2016-08-15       Impact factor: 21.405

3.  Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.

Authors:  Bradley A Maron; Edward Hess; Thomas M Maddox; Alexander R Opotowsky; Ryan J Tedford; Tim Lahm; Karen E Joynt; Daniel J Kass; Thomas Stephens; Maggie A Stanislawski; Erik R Swenson; Ronald H Goldstein; Jane A Leopold; Roham T Zamanian; Jean M Elwing; Mary E Plomondon; Gary K Grunwald; Anna E Barón; John S Rumsfeld; Gaurav Choudhary
Journal:  Circulation       Date:  2016-02-12       Impact factor: 29.690

4.  A novel channelopathy in pulmonary arterial hypertension.

Authors:  Lijiang Ma; Danilo Roman-Campos; Eric D Austin; Mélanie Eyries; Kevin S Sampson; Florent Soubrier; Marine Germain; David-Alexandre Trégouët; Alain Borczuk; Erika Berman Rosenzweig; Barbara Girerd; David Montani; Marc Humbert; James E Loyd; Robert S Kass; Wendy K Chung
Journal:  N Engl J Med       Date:  2013-07-25       Impact factor: 91.245

5.  Clinical Relevance of Fluid Challenge in Patients Evaluated for Pulmonary Hypertension.

Authors:  Michele D'Alto; Emanuele Romeo; Paola Argiento; Yoshiki Motoji; Anna Correra; Giovanni Maria Di Marco; Agostino Mattera Iacono; Rosaria Barracano; Antonello D'Andrea; Gaetano Rea; Berardo Sarubbi; Maria Giovanna Russo; Robert Naeije
Journal:  Chest       Date:  2016-08-26       Impact factor: 9.410

6.  Metabolic Reprogramming Regulates the Proliferative and Inflammatory Phenotype of Adventitial Fibroblasts in Pulmonary Hypertension Through the Transcriptional Corepressor C-Terminal Binding Protein-1.

Authors:  Min Li; Suzette Riddle; Hui Zhang; Angelo D'Alessandro; Amanda Flockton; Natalie J Serkova; Kirk C Hansen; Radu Moldovan; B Alexandre McKeon; Maria Frid; Sushil Kumar; Hong Li; Hongbing Liu; Angela Caánovas; Juan F Medrano; Milton G Thomas; Dijana Iloska; Lydie Plecitá-Hlavatá; Petr Ježek; Soni Pullamsetti; Mehdi A Fini; Karim C El Kasmi; QingHong Zhang; Kurt R Stenmark
Journal:  Circulation       Date:  2016-08-25       Impact factor: 29.690

7.  Executive Summary of the American Heart Association and American Thoracic Society Joint Guidelines for Pediatric Pulmonary Hypertension.

Authors:  Steven H Abman; D Dunbar Ivy; Stephen L Archer; Kevin Wilson
Journal:  Am J Respir Crit Care Med       Date:  2016-10-01       Impact factor: 21.405

8.  TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling.

Authors:  Liam A Hurst; Benjamin J Dunmore; Lu Long; Alexi Crosby; Rafia Al-Lamki; John Deighton; Mark Southwood; Xudong Yang; Marko Z Nikolic; Blanca Herrera; Gareth J Inman; John R Bradley; Amer A Rana; Paul D Upton; Nicholas W Morrell
Journal:  Nat Commun       Date:  2017-01-13       Impact factor: 14.919

9.  Loss of prolyl hydroxylase domain protein 2 in vascular endothelium increases pericyte coverage and promotes pulmonary arterial remodeling.

Authors:  Shuo Wang; Heng Zeng; Xue-Jiao Xie; Yong-Kang Tao; Xiaochen He; Richard J Roman; Judy L Aschner; Jian-Xiong Chen
Journal:  Oncotarget       Date:  2016-09-13

10.  Identification of MicroRNA-124 as a Major Regulator of Enhanced Endothelial Cell Glycolysis in Pulmonary Arterial Hypertension via PTBP1 (Polypyrimidine Tract Binding Protein) and Pyruvate Kinase M2.

Authors:  Paola Caruso; Benjamin J Dunmore; Kenny Schlosser; Sandra Schoors; Claudia Dos Santos; Carol Perez-Iratxeta; Jessie R Lavoie; Hui Zhang; Lu Long; Amanda R Flockton; Maria G Frid; Paul D Upton; Angelo D'Alessandro; Charaka Hadinnapola; Fedir N Kiskin; Mohamad Taha; Liam A Hurst; Mark L Ormiston; Akiko Hata; Kurt R Stenmark; Peter Carmeliet; Duncan J Stewart; Nicholas W Morrell
Journal:  Circulation       Date:  2017-09-26       Impact factor: 29.690
View more
  2 in total

1.  Mechanism of Phellodendron and Anemarrhena Drug Pair on the Treatment of Liver Cancer Based on Network Pharmacology and Bioinformatics.

Authors:  Xiaofeng Ruan; Wenyuan Li; Peng Du; Yao Wang
Journal:  Front Oncol       Date:  2022-04-07       Impact factor: 5.738

2.  FHIT, a Novel Modifier Gene in Pulmonary Arterial Hypertension.

Authors:  Svenja Dannewitz Prosseda; Xuefei Tian; Kazuya Kuramoto; Mario Boehm; Deepti Sudheendra; Kazuya Miyagawa; Fan Zhang; David Solow-Cordero; Joshua C Saldivar; Eric D Austin; James E Loyd; Lisa Wheeler; Adam Andruska; Michele Donato; Lingli Wang; Kay Huebner; Ross J Metzger; Purvesh Khatri; Edda Spiekerkoetter
Journal:  Am J Respir Crit Care Med       Date:  2019-01-01       Impact factor: 30.528
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.